GlassScriptPhysician profile
Michelle C Elliott
NPI 1437973625
$3,236.23
in general payments reported to CMS, 2019-2025
19 companies · $3,236 in 2025
The $3,236 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $553.43 | 2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $395.96 | 2025 | Wainua, Lokelma, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.31 | 2025 | Jardiance |
| Pfizer INC. | $317.47 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $212.84 | 2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $163.47 | 2025 | Sapien 3 Ultra Resilia |
| Esperion Therapeutics, INC. | $159.46 | 2025 | Nexletol |
| Novo Nordisk INC | $156.52 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $152.61 | 2025 | |
| Alnylam Pharmaceuticals INC. | $144.59 | 2025 | Amvuttra |
| Scpharmaceuticals INC. | $135.67 | 2025 | |
| Bridgebio Pharma, INC. | $102.81 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $79.90 | 2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $73.44 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.45 | 2025 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $60.56 | 2025 | Assure Wcd |
| Abiomed | $38.44 | 2025 | |
| Philips North America LLC | $33.89 | 2025 | Extended Holter |
| Regeneron Healthcare Solutions, INC. | $24.41 | 2025 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.